Literature DB >> 23677320

HLA-B*44 is associated with a lower viral set point and slow CD4 decline in a cohort of Chinese homosexual men acutely infected with HIV-1.

Xin Zhang1, XiaoJie Huang, Wei Xia, WeiHua Li, Tong Zhang, Hao Wu, XiaoNing Xu, HuiPing Yan.   

Abstract

HLA class I alleles have been shown to have differential impacts on the viral load and the outcome of HIV-1 disease progression. In this study, HLA class I types from residents of China with acute HIV-1 infection, diagnosed between 2006 and 2011, were identified and the association between expression of individual HLA alleles and the level of the set point viral load was analyzed. A lower level of set point viral load was found to be associated with the Bw4 homozygote on HLA-B alleles. B*44 and B*57 alleles have also been found to be associated with lower set point viral load. The set point viral load of B*44-positive individuals homozygous for Bw4 was significantly lower than that of B*44-negative individuals homozygous for Bw4 (P = 0.030). The CD4 count declined to <350 in fewer B*44-positive individuals than B*44-negative individuals (X(2) = 7.295, P = 0.026). B*44-positive individuals had a lower magnitude of p24 pool-specific T cell responses than B*44-negative individuals homozygous for Bw4, though this was not statistically significant. The p24 pool-specific T cell responses were also inversely correlated with lower viral load (rs = -0.88, P = 0.033). Six peptides within p24 were recognized to induce the specific-T cell response in B*44-positive individuals, and the peptide breadth of response was same as that in B*44-negative individuals homozygous for Bw4, but the median magnitude of specific-T cell responses to the recognized peptides in B*44-positive individuals was lower than that in B*44-negative individuals homozygous for Bw4 (P = 0.049). These findings imply that weak p24-specific CD8(+) T cell responses might play an important role in the control of HIV viremia in B*44 allele-positive individuals. Such studies might contribute to the development of future therapeutic strategies that take into account the genetic background of the patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677320      PMCID: PMC3697455          DOI: 10.1128/CVI.00015-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  32 in total

Review 1.  HIV-1 diversity versus HLA class I polymorphism.

Authors:  Henry A F Stephens
Journal:  Trends Immunol       Date:  2005-01       Impact factor: 16.687

2.  AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.

Authors:  Xiaojiang Gao; Arman Bashirova; Astrid K N Iversen; John Phair; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; Marcus Altfeld; Stephen J O'Brien; Mary Carrington
Journal:  Nat Med       Date:  2005-11-20       Impact factor: 53.440

3.  Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection.

Authors:  John W Mellors; Joseph B Margolick; John P Phair; Charles R Rinaldo; Roger Detels; Lisa P Jacobson; Alvaro Muñoz
Journal:  JAMA       Date:  2007-06-06       Impact factor: 56.272

4.  High-resolution HLA alleles and haplotypes in the United States population.

Authors:  Martin Maiers; Loren Gragert; William Klitz
Journal:  Hum Immunol       Date:  2007-05-24       Impact factor: 2.850

5.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Authors:  Photini Kiepiela; Alasdair J Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja J Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Michael Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

6.  Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.

Authors:  Marjon Navis; Ingrid Schellens; Debbie van Baarle; José Borghans; Peter van Swieten; Frank Miedema; Neeltje Kootstra; Hanneke Schuitemaker
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

7.  Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.

Authors:  R A Kaslow; M Carrington; R Apple; L Park; A Muñoz; A J Saah; J J Goedert; C Winkler; S J O'Brien; C Rinaldo; R Detels; W Blattner; J Phair; H Erlich; D L Mann
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

8.  Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.

Authors:  J W Mellors; C R Rinaldo; P Gupta; R M White; J A Todd; L A Kingsley
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

9.  A whole-genome association study of major determinants for host control of HIV-1.

Authors:  Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; Bruno Ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; José M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
Journal:  Science       Date:  2007-07-19       Impact factor: 47.728

10.  KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.

Authors:  Ying Qi; Maureen P Martin; Xiaojiang Gao; Lisa Jacobson; James J Goedert; Susan Buchbinder; Gregory D Kirk; Stephen J O'Brien; John Trowsdale; Mary Carrington
Journal:  PLoS Pathog       Date:  2006-08       Impact factor: 6.823

View more
  6 in total

1.  Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.

Authors:  Shannon R Roff; Missa P Sanou; Mobeen H Rathore; Jay A Levy; Janet K Yamamoto
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China.

Authors:  Chuan He; Xiaoxu Han; Hui Zhang; Fanming Jiang; Minghui An; Bin Zhao; Haibo Ding; Zining Zhang; Tao Dong; Hong Shang
Journal:  Med Microbiol Immunol       Date:  2019-03-08       Impact factor: 3.402

3.  Cigarette smoking is associated with high HIV viral load among adults presenting for antiretroviral therapy in Vietnam.

Authors:  Todd M Pollack; Hao T Duong; Thuy T Pham; Cuong D Do; Donn Colby
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

4.  A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.

Authors:  Zachary A Silver; Gordon M Dickinson; Michael S Seaman; Ronald C Desrosiers
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

5.  KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in HLA-B Bw4 Homozygous Individuals.

Authors:  Xin Zhang; Xiaofan Lu; Christiane Moog; Lin Yuan; Zhiying Liu; Zhen Li; Wei Xia; Yuefang Zhou; Hao Wu; Tong Zhang; Bin Su
Journal:  Front Immunol       Date:  2018-08-10       Impact factor: 7.561

Review 6.  A SYSTEMATIC REVIEW ON THE INFLUENCE OF HLA-B POLYMORPHISMS ON HIV-1 MOTHER-TO-CHILD-TRANSMISSION.

Authors:  Juan Manuel Cubillos Angulo; Taryn Ariadna Castro Cuesta; Eliane Pereira Menezes; Celia Pedroso; Carlos Brites
Journal:  Braz J Infect Dis       Date:  2019-02-14       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.